Delivery Order SPE2DB22D9304-SPE2DB25FSTB0
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $61,538.77 for MACI 3cm x 5cm implant sheets. This firm fixed-price contract, awarded on September 5, 2025, with an ultimate completion date of September 26, 2025, was issued by the Defense Logistics Agency without a set-aside designation. The delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $61,902.91 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. The award, issued on July 25, 2025, with an ultimate completion date of August 15, 2025, operates under a firm fixed-price contract type with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $61,538.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. This firm fixed-price delivery order was awarded on September 10, 2025, with an ultimate completion date of October 1, 2025, and carries no set-aside designation. The contract represents a discrete order issued under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a $61,538.77 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 15, 2025, for MACI 3cm x 5cm implant sheets, with an ultimate completion date of October 6, 2025. This delivery order was issued without a set-aside designation to the woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. MACI (matrix-applied characterized autologous mesenchymal cells) implants are advanced regenerative medicine products...
- The Defense Logistics Agency awarded a delivery order valued at $61,902.91 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. This firm fixed-price delivery order was awarded on July 14, 2025, with an ultimate completion date of August 4, 2025, and represents no set-aside designation. The award falls under DMS Pharmaceutical Group's existing single-award Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $61,538.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. This firm fixed-price delivery order, issued on September 18, 2025, is scheduled for ultimate completion by October 9, 2025, with performance taking place in Park Ridge, Illinois. The contract was awarded without a set-aside designation, allowing the...
- The Defense Logistics Agency awarded a delivery order valued at $61,538.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. This firm fixed-price delivery order was awarded on September 10, 2025, with an ultimate completion date of October 1, 2025, and carries no set-aside designation. The award was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $61,902.91 by the Defense Logistics Agency (DLA) on July 11, 2025, for MACI 3cm x 5cm implant sheets. The delivery order, which carries an ultimate completion date of August 1, 2025, was issued without a set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $61,902.91 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on August 26, 2025, for MACI 3cm x 5cm implant sheets, with an ultimate completion date of September 17, 2025. This delivery order was issued without a set-aside designation and represents a discrete procurement under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026. The Park Ridge, Illinois-based woman-owned...
- The Defense Logistics Agency awarded a delivery order valued at $61,902.91 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of MACI 3cm x 5cm implant sheets. The contract is a firm fixed-price delivery order with an ultimate completion date of August 28, 2025, and was awarded on August 7, 2025. This award utilizes no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open market...
- SPE2DB22D9304Indefinite Delivery Contract
- SPE2DB22D9304-SPE2DB25FSTB0Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $61,538.77 to DMS Pharmaceutical Group Inc. for MACI 3cm x 5cm implant sheets. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its facility in Park Ridge. The contract carries no set-aside designation and has an ultimate completion date of September 24, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies. MACI (matrix-applied characterized autologous cultured chondrocytes) implants are specialized biologics used for cartilage repair and regeneration, particularly in orthopedic applications. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through consistent performance on DLA contracts covering diverse medical products ranging from prescription medications to specialty biologics and vaccines. The company's federal procurement portfolio demonstrates its capacity to distribute both branded and generic pharmaceutical products to military and federal healthcare facilities nationwide, making it well-positioned to supply specialized medical devices such as MACI implants to Department of Defense healthcare sites.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $61.5k | 9/3/25 |